← Every company
ACADIA Pharmaceuticals Inc SEC Filings
What ACADIA Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ACAD overview →Filings on file
118
since Nov 7, 2016
Warning signs
0
none filed
Last results
Aug 4, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 29, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 1, 2026 | Executive or director change 8-K | Read ↗ |
| Mar 5, 2026 | Executive or director change 8-K | Read ↗ |
| Nov 3, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 20, 2024 | Executive or director change 8-K | Read ↗ |
| Sep 23, 2024 | Executive or director change 8-K | Read ↗ |
| May 29, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 31, 2024 | Executive or director change 8-K | Read ↗ |
| Oct 28, 2022 | Executive or director change 8-K | Read ↗ |
| Oct 13, 2022 | Executive or director change 8-K | Read ↗ |
| Jun 10, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 8, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 14, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 5, 2021 | Executive or director change 8-K | Read ↗ |
| Sep 2, 2021 | Executive or director change 8-K | Read ↗ |
| Jan 27, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 1, 2020 | Executive or director change 8-K | Read ↗ |
| Aug 6, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 29, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Nov 7, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 28, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 1, 2019 | Executive or director change 8-K | Read ↗ |
| Nov 20, 2018 | Executive or director change 8-K | Read ↗ |
| Nov 5, 2018 | Executive or director change 8-K | Read ↗ |
| Jul 23, 2018 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jun 15, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 31, 2017 | Executive or director change 8-K | Read ↗ |
Source: ACADIA Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ACAD
Company overviewEverything on ACAD in one place, with the price.Insider tradingWhat ACAD's own officers and directors buy and sell.Who owns itEvery manager reporting a position in ACAD.Funds holding itWhich funds and ETFs hold ACAD, and how big a bet.LobbyingWhat ACAD spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ACAD's account, and who they worked for.PatentsWhat ACAD is filing at the patent office.